These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9034559)

  • 1. Heparin-induced thrombocytopenia with thrombotic complications during prophylactic treatment with low-molecular-weight heparin.
    de Raucourt E; Vinsonneau C; Juvin K; Fischer AM; Meyer G
    Blood Coagul Fibrinolysis; 1996 Nov; 7(8):786-8. PubMed ID: 9034559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
    Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
    Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/low molecular weight heparin after hip and knee prosthesis implantation].
    Mahlfeld K; Franke J; Schaeper O; Kayser R; Grasshoff H
    Unfallchirurg; 2002 Apr; 105(4):327-31. PubMed ID: 12066471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin-induced thrombocytopenia and thrombosis.
    Peters FP; Doevendans PA; Erdkamp FL; Van Der Ent FW; De Heer F
    Eur J Haematol; 1996 May; 56(5):329-30. PubMed ID: 8641411
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
    Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
    Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparin-associated thrombocytopenia, thrombosis and embolism. Side effects of thromboembolism prevention with low molecular weight heparin enoxaparin?].
    Mohr VD; Lenz J
    Chirurg; 1991 Sep; 62(9):686-90. PubMed ID: 1660803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
    Warkentin TE; Levine MN; Hirsh J; Horsewood P; Roberts RS; Gent M; Kelton JG
    N Engl J Med; 1995 May; 332(20):1330-5. PubMed ID: 7715641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin-associated thrombocytopenia caused by low-molecular-weight heparin].
    Köninger J; Greinacher A; Müller-Beissenhirtz W; Strosche H
    Unfallchirurg; 1995 Jan; 98(1):49-51. PubMed ID: 7886465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology, epidemiology, diagnosis and treatment of heparin-induced thrombocytopenia (HIT).
    Picker SM; Gathof BS
    Eur J Med Res; 2004 Apr; 9(4):180-5. PubMed ID: 15210398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia.
    Gleichgerrcht E; Lim MY; Turan TN
    Neurologist; 2017 Nov; 22(6):241-244. PubMed ID: 29095327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
    Ozsu S; Korkmaz A; Bülbül Y; Oztuna F; Ozlü T
    Tuberk Toraks; 2011; 59(2):178-83. PubMed ID: 21740395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A benchmark for platelet count monitoring with low-molecular-weight heparin: expanding implementation of National Patient Safety Goals.
    Spinler SA
    Ann Pharmacother; 2009 Sep; 43(9):1519-21. PubMed ID: 19690223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
    Franke J; Schaeper O; Kayser R; Mahlfeld K
    Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia after liver transplantation.
    Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Makuuchi M
    Transplant Proc; 2008 Jun; 40(5):1518-21. PubMed ID: 18589141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Warkentin TE; Greinacher A
    Chest; 2004 Sep; 126(3 Suppl):311S-337S. PubMed ID: 15383477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Standards and perspectives for thromboembolism prophylaxis].
    Rader CP
    Orthopade; 2007 Jun; 36(6):560, 562-6. PubMed ID: 17546440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia with thrombotic complications.
    Aburahma AF; Malik FS; Boland JP
    W V Med J; 1992 Mar; 88(3):95-100. PubMed ID: 1574877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two surgical case reports showing atypical heparin-induced thrombocytopenia].
    Höhnke C; Haas S
    Chirurg; 2007 Feb; 78(2):138, 140-1. PubMed ID: 17252251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.
    Sartori M; Favaretto E; Migliaccio L; Guazzaloca G; Legnani C; Palareti G; Cosmi B
    Thromb Res; 2016 Mar; 139():154-7. PubMed ID: 26916314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
    Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
    Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.